Global Plasmid DNA (pDNA) Production and Manufacturing Market Growth (Status and Outlook) 2024-2030

Global Plasmid DNA (pDNA) Production and Manufacturing Market Growth (Status and Outlook) 2024-2030

Plasmid DNA (pDNA) Production and Manufacturing is a critical process in the biotechnology and pharmaceutical industries, primarily used for gene therapy, vaccine production, and the development of genetic engineering tools. Plasmid DNA is a small, circular piece of DNA that can replicate independently of chromosomal DNA in bacteria. The production of high-quality plasmid DNA is essential for various applications, including clinical trials and commercial therapies.

The global Plasmid DNA (pDNA) Production and Manufacturing market size is projected to grow from US$ 3552 million in 2024 to US$ 5972 million in 2030; it is expected to grow at a CAGR of 9.0% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Plasmid DNA (pDNA) Production and Manufacturing Industry Forecast” looks at past sales and reviews total world Plasmid DNA (pDNA) Production and Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Plasmid DNA (pDNA) Production and Manufacturing sales for 2023 through 2029. With Plasmid DNA (pDNA) Production and Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasmid DNA (pDNA) Production and Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Plasmid DNA (pDNA) Production and Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Plasmid DNA (pDNA) Production and Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasmid DNA (pDNA) Production and Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasmid DNA (pDNA) Production and Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasmid DNA (pDNA) Production and Manufacturing.

United States market for Plasmid DNA (pDNA) Production and Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Plasmid DNA (pDNA) Production and Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Plasmid DNA (pDNA) Production and Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Plasmid DNA (pDNA) Production and Manufacturing players cover Charles River Laboratories, Patheon, AGC Biologics, Creative Biolabs, Synbio Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasmid DNA (pDNA) Production and Manufacturing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA

Segmentation by Application:
Cancers
Inherited Disorders
Viral Infections
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA

Segmentation by Application:
Cancers
Inherited Disorders
Viral Infections
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Patheon
AGC Biologics
Creative Biolabs
Synbio Technologies
Aldevron
Takara Bio
Recipharm
Eurogentec
Akron Biotech
Catalent Biologics
Xpress Biologics
Esco Aster
Biovian
GenScript ProBio
Andelyn Biosciences
WuXi Advanced Therapies
Waisman Biomanufacturing
GenScript Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.